Nu Skin Enterprises, Inc.

NYQ: NUS

Live Quote

📈 ZcoreAI Score

Our AI model analyzes Nu Skin Enterprises, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.

Get NUS Z-Score →

About Nu Skin Enterprises, Inc.

Consumer Defensive Household & Personal Products

Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa, ageLOC LumiSpa iO, and Nu Skin RenuSpa iO; ageLOC TruFace and ageLOC LumiSpa cleansers and devices; Prysm iO, a data-enabled wellness device; and Nutricentials beauty and Beauty Focus wellness brands. The company also provides wellness products, such as ageLOC TRME, LifePak, and Beauty Focus. In addition, it is the research and product development of skin care products, nutritional supplements, and devices. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center and independent marketers. It serves Mainland China; South Korea; Southeast Asia/Pacific, which includes Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Australia, New Zealand and other markets; Americas, comprising Canada, Latin America and the United States; Japan; Hong Kong/Taiwan, consists of Macau; and Europe & Africa, which includes markets in Europe as well as South Africa. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.

📊 Fundamental Analysis

Nu Skin Enterprises, Inc. demonstrates exceptional profitability, with a profit margin of 10.8%.

The company recently reported -16.9% revenue growth, which is negative, indicating a recent decline in revenue.

Return on Equity (ROE) is 22.0%, which exceeds the Consumer Defensive sector average, reflecting efficient capital allocation.

At a current price of $7.52, NUS currently sits at the 24th percentile of its 52-week range (Range: $5.32 - $14.62).

💰 Valuation Insight

NUS trades at a 89.3% discount (PE: 2.36), which may represent a value opportunity given the sector average of 22.00. Analysts anticipate some earnings pressure, with a higher forward PE.

🏥 Financial Health

✅ Profit Margin Excellent

✅ Debt/Equity Excellent

🔴 Revenue Growth Weak

⚠️ Return on Equity Moderate

⚠️ Beta (Risk) Moderate Volatility

Key Financials

Market Cap

$369.81M

Trailing P/E

2.36

Forward P/E

5.74

Beta (5Y)

1.07

52W High

$14.62

52W Low

$5.32

Avg Volume

555K

Day High

Day Low

Get NUS Z-Score on Dashboard 🚀